The focus returns to Sofi, with Dr. Stock providing insights into the stock's current technical analysis. He mentions key levels, such as the 50-day and 200-day moving averages, and discusses the potential impact of a death cross. Dr. Stock remains positive about Sofi's long-term potential, but he acknowledges the short-term challenges the stock may face.